- 专利标题： Bicyclic heterocycles as FGFR4 inhibitors
-
申请号： US17238409申请日： 2021-04-23
-
公开(公告)号： US11667635B2公开(公告)日： 2023-06-06
- 发明人: Liang Lu , Liangxing Wu , Ding-Quan Qian , Wenqing Yao
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation,Incyte Holdings Corporation
- 当前专利权人： Incyte Corporation,Incyte Holdings Corporation
- 当前专利权人地址： US DE Wilmington; US DE Wilmington
- 代理机构： Fish & Richardson P.C.
- 主分类号： C07D471/04
- IPC分类号： C07D471/04
摘要：
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.
公开/授权文献
- US20220009921A1 BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS 公开/授权日：2022-01-13
信息查询
